Out of the Lab: Operationalizing Cell and Gene Therapy
Designing for Resilience: Why CGT Supply Chain Begins Years Before Tech Transfer | Mehran Bhatti
What was said
to control variability j and j opted a different route if they chose to do their own process tech transferred that to all the a3c sites okay and have that one process how they then cryopreserved the cells and then shifted towards their processing and manufacturing facilities